These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11914005)

  • 1. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage.
    Tsui JC; Dashwood MR
    Eur J Vasc Endovasc Surg; 2002 Mar; 23(3):202-8. PubMed ID: 11914005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular biology of coronary bypass grafts. Literature review].
    Barandon L; Kindo M; Perrault LP; Hebert Y; Cartier R; Bouchard D; Demers P; Pagé P; Carrier M; Pellerin M
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1206-15. PubMed ID: 15669362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy and coronary artery bypass grafting: current perspectives.
    George SJ; Channon KM; Baker AH
    Curr Opin Mol Ther; 2006 Aug; 8(4):288-94. PubMed ID: 16955691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
    Dashwood MR
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutics of vein graft intimal hyperplasia: 100 years on.
    Wallitt EJ; Jevon M; Hornick PI
    Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo h-VEGF165 gene transfer improves early endothelialisation and patency in synthetic vascular grafts.
    Lahtinen M; Blomberg P; Baliulis G; Carlsson F; Khamis H; Zemgulis V
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):383-90. PubMed ID: 17210256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing coronary artery bypass graft patency.
    Metcalfe MJ; Lip GY; Dargie HJ
    Cardiovasc Surg; 1994 Dec; 2(6):679-85. PubMed ID: 7858984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 11. Disruption of graft endothelium correlates with early failure after off-pump coronary artery bypass surgery.
    Manchio JV; Gu J; Romar L; Brown J; Gammie J; Pierson RN; Griffith B; Poston RS
    Ann Thorac Surg; 2005 Jun; 79(6):1991-8. PubMed ID: 15919298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo (animal) models of vein graft disease.
    Schachner T; Laufer G; Bonatti J
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):451-63. PubMed ID: 16870461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery.
    Cho KR; Jeong DS; Kim KB
    Eur J Cardiothorac Surg; 2007 Nov; 32(5):718-23. PubMed ID: 17822913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of vein graft neointimal hyperplasia.
    Schachner T
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1065-72. PubMed ID: 16678591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow dynamics of the St Jude Medical Symmetry aortic connector vein graft anastomosis do not contribute to the risk of acute thrombosis.
    Redaelli A; Maisano F; Ligorio G; Cattaneo E; Montevecchi FM; Alfieri O
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):117-23. PubMed ID: 15224030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial.
    Desai ND; Naylor CD; Kiss A; Cohen EA; Feder-Elituv R; Miwa S; Radhakrishnan S; Dubbin J; Schwartz L; Fremes SE;
    Circulation; 2007 Feb; 115(6):684-91. PubMed ID: 17283268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for studying vein graft failure and therapeutic interventions.
    Thomas AC
    Curr Opin Pharmacol; 2012 Apr; 12(2):121-6. PubMed ID: 22281067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The saphenous vein graft diseases].
    Yavuz T; Kutsal A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial.
    Souza DS; Johansson B; Bojö L; Karlsson R; Geijer H; Filbey D; Bodin L; Arbeus M; Dashwood MR
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):373-8. PubMed ID: 16872965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low compliance and arterial graft occlusion.
    Kidson IG; Abbott WM
    Circulation; 1978 Sep; 58(3 Pt 2):I1-4. PubMed ID: 14740668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.